TY - JOUR T1 - COVID-19 Case Series at UnityPoint Health St. Luke’s Hospital in Cedar Rapids, IA JF - medRxiv DO - 10.1101/2020.07.17.20156521 SP - 2020.07.17.20156521 AU - Dianna Edwards AU - Daniel McGrail Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/07/19/2020.07.17.20156521.abstract N2 - A retrospective, descriptive study of all patients tested for SARS-CoV2 on admission for illness to a community hospital in Iowa from 3/21/20 thru 6/14/20 consisted of evaluation as to demographics, presentation and hospital course. Ninety-one patients were SARS-CoV2 PCR+ with 63% being male and a median age of 60. Cardiovascular disease was a significant comorbidity in the PCR+ group. Fever, cough, dyspnea, nausea, emesis, diarrhea, headache and myalgias were significantly more common in that group, as was an elevated CRP, LDH, serum ferritin and transaminases. Overall survival of the COVID-19 patients was 88%, 77% in the critically ill, 59% of those mechanically ventilated and 33% of those requiring new dialysis. Survival was 93% in those not receiving any antivirals. Survival of those treated with hydroxychloroquine-azithromycin was 92%, compared to 86% of those treated with hydroxychloroquine alone. The latter two groups were significantly more ill than the untreated group. A transition from an early intubation strategy to aggressive utilization of high flow nasal cannula and noninvasive ventilation(i.e BiPAP) was successful in freeing up ICU resources.Competing Interest StatementDr. Edwards is employed by Unity Point/St. Luke's Hospital.Clinical TrialNone. It was a retrospective case series.Funding StatementNo specific funding was available for the study. Dr. Edwards is employed by Unity Point St. Luke's Hospital.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB at Unity Point St. Luke's Hospital.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that the study is based on is derived from the records of St. Luke's Hospital. The date is in possession of the authors, Dr. McGrail and Dr. Edwards. ER -